Edition:
United Kingdom

SINOPHARM GROUP CO LTD (1099.HK)

1099.HK on Hong Kong Stock

33.90HKD
6:53am GMT
Change (% chg)

HK$0.10 (+0.30%)
Prev Close
HK$33.80
Open
HK$33.95
Day's High
HK$34.40
Day's Low
HK$33.60
Volume
3,907,109
Avg. Vol
5,384,937
52-wk High
HK$45.65
52-wk Low
HK$29.35

Latest Key Developments (Source: Significant Developments)

Sinopharm Group Co Posts HY Profit Attributable RMB2.68 Bln
Monday, 27 Aug 2018 

Aug 27 (Reuters) - SINOPHARM GROUP CO LTD <1099.HK>::H1 REVENUE RMB 147.49 BILLION VERSUS RMB137.77 BILLION.HY PROFIT ATTRIBUTABLE RMB2.68 BILLION VERSUS RMB2.76 BILLION.  Full Article

China National Medicines unit to set up medical supply chain management JV with partner
Thursday, 12 Jul 2018 

July 12(Reuters) - China National Medicines Corp Ltd <600511.SS>:Says co's Beijing-based unit plans to invest 12 million yuan to set up a Beijing-based medical supply chain management JV with partner, with registered capital of 20 million yuan.Says unit will hold 60 percent stake in the JV.  Full Article

Sinopharm Group To Buy 60 Pct stake In China National Scientific Instruments And Materials
Wednesday, 11 Jul 2018 

July 11 (Reuters) - SINOPHARM GROUP CO LTD <1099.HK>::TO BUY 60% STAKE IN CHINA NATIONAL SCIENTIFIC INSTRUMENTS AND MATERIALS CO. LTD HELD BY CHINA NATIONAL PHARMACEUTICAL GROUP CO.DEAL FOR RMB5.11 BILLION.CONSIDERATION TO BE SATISFIED BY ISSUE OF 204.6 MILLION DOMESTIC SHARES BY CO TO CNPGC AT RMB24.97 PER CONSIDERATION SHARE.  Full Article

Sinopharm Group Posts Qtrly Net Profit Attributable RMB842.7 Million
Friday, 27 Apr 2018 

April 27 (Reuters) - SINOPHARM GROUP CO LTD <1099.HK>::QTRLY TOTAL OPERATING REVENUE RMB72.69 BILLION VERSUS RMB68.42 BILLION.QTRLY NET PROFIT ATTRIBUTABLE RMB842.7 MILLION VERSUS RMB1.25 BILLION.  Full Article

Sinopharm Group Co Posts ‍FY Profit Of RMB5.28 Bln
Sunday, 25 Mar 2018 

March 26 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::‍PROPOSED FINAL DIVIDEND OF RMB0.57 PER ORDINARY SHARE​.‍FY REVENUE RMB277.71 BILLION VERSUS RMB258.40 BILLION.‍FY PROFIT ATTRIBUTABLE RMB 5.28 BILLION VERSUS RMB 4.65 BILLION ​.  Full Article

Sinopharm Group Co's Board Resolves To Propose Issue Of Corporate Bonds In China
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::BOARD RESOLVED TO PROPOSE ISSUE OF CORPORATE BONDS IN PRC; ISSUE SIZE OF NO MORE THAN RMB10 BILLION.  Full Article

Virtual Incision Announces $18 Mln Series B Funding For Miniaturized Surgical Robots
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Virtual Incision Corp::VIRTUAL INCISION ANNOUNCES $18 MILLION SERIES B FUNDING FOR MINIATURIZED SURGICAL ROBOTS.VIRTUAL INCISION CORPORATION - SERIES B FUNDING ROUND WAS CO-LED BY SINOPHARM CAPITAL & BLUESTEM CAPITAL.  Full Article

Sinopharm Group Says To Acquire Pudong Medicines And Herbs
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::‍CO TO ACQUIRE 100% EQUITY INTEREST IN PUDONG MEDICINES AND HERBS FROM CHINA NATIONAL PHARMACEUTICAL GROUP CORP FOR RMB217.5 MILLION.  Full Article

China Vanguard You Champion says through unit enters into joint venture deal with Sino-TCM
Friday, 24 Nov 2017 

Nov 24 (Reuters) - China Vanguard You Champion Holdings Ltd <8156.HK> ::‍Co through its unit enters into a joint venture agreement with Sinopharm Traditional Chinese Medicine Co..  Full Article

Sinopharm Group says Li Zhiming proposes to cease to serve as president​
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::Li Zhiming proposed to cease to serve as president​.‍Li zhiming continues to serve as chairman of board​.‍Liu yong ceased to serve as vice president​.‍Board resolved to appoint liu yong as president of company​.  Full Article

Hong Kong stocks fall as Huawei exec arrest rekindles trade worries

Dec 7 Hong Kong stocks closed lower on Friday, marking the end of a volatile week of trading, as the arrest of a senior Huawei executive dampened hopes of a lasting resolution to the U.S.-China trade conflict.